A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia

Conditions

• Cachexia-Anorexia Syndrome
• Solid Tumor Malignancies

Interventions

• DRUG: SXRN Injection

Sponsor

Jiangsu Nutai Biologics Co., Ltd

Collaborators

• [object Object]